Woodline Partners’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-132,117
| Closed | -$2.9M | – | 757 |
|
|
2021
Q4 | $2.9M | Buy |
132,117
+45,694
| +53% | +$1M | 0.04% | 369 |
|
|
2021
Q3 | $2.33M | Buy |
86,423
+47,715
| +123% | +$1.29M | 0.04% | 387 |
|
|
2021
Q2 | $932K | Sell |
38,708
-47,121
| -55% | -$1.13M | 0.02% | 444 |
|
|
2021
Q1 | $3.72M | Sell |
85,829
-17,624
| -17% | -$764K | 0.08% | 222 |
|
|
2020
Q4 | $4.29M | Buy |
+103,453
| New | +$4.29M | 0.11% | 163 |
|